Literature DB >> 23758174

Detection of lymphangiogenesis by near-infrared fluorescence imaging and responses to VEGF-C during healing in a mouse full-dermis thickness wound model.

Mary A Hall1, Holly Robinson, Wenyaw Chan, Eva M Sevick-Muraca.   

Abstract

Noninvasive, longitudinal near-infrared fluorescence (NIRF) imaging was used to detect and quantify lymphangiogenesis following a full-dermis thickness incision in the presence and absence of locally administered vascular endothelial growth factor-C (VEGF-C), a well-known regulator of lymphangiogenesis. Peripheral cytokines/chemokines were also measured in treated and sham-injected animals. Lymphangiogenesis was detected via NIRF imaging by day 7-8 and confirmed by intravital microscopy, while angiogenesis was observed by day 2-3 postincision (PI). All lymph vessel parameters quantified were significantly greater on wounded vs. nonwounded sides of mice. Lymph vessel parameters appeared larger on wounded sides of VEGF-C- relative to NaCl-treated mice, although differences were not significant. Interleukin-1α and interleukin-22 were significantly elevated at day 7 PI relative to respective preincision levels in VEGF-C-treated mice, and decreased by day 21 PI to levels nearing those measured preincision. For the majority of cytokines/chemokines measured, mean responses were significantly greater in VEGF-C- vs. NaCl-treated animals. Local VEGF-C administration may stimulate lymphangiogenesis during tissue repair and regeneration via mediating systemic cytokine/chemokine levels. NIRF imaging can be utilized to detect lymphangiogenesis during wound healing, and offers a promising platform to complement current methods for monitoring wound status and studying the effects of growth factors on healing.
© 2013 by the Wound Healing Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23758174     DOI: 10.1111/wrr.12063

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  7 in total

1.  An abnormal lymphatic phenotype is associated with subcutaneous adipose tissue deposits in Dercum's disease.

Authors:  John C Rasmussen; Karen L Herbst; Melissa B Aldrich; Chinmay D Darne; I-Chih Tan; Banghe Zhu; Renie Guilliod; Caroline E Fife; Erik A Maus; Eva M Sevick-Muraca
Journal:  Obesity (Silver Spring)       Date:  2014-07-09       Impact factor: 5.002

2.  Characterization of internodal collecting lymphatic vessel function after surgical removal of an axillary lymph node in mice.

Authors:  Sunkuk Kwon; Roger E Price
Journal:  Biomed Opt Express       Date:  2016-03-03       Impact factor: 3.732

3.  VEGF Receptor-2 Activation Mediated by VEGF-E Limits Scar Tissue Formation Following Cutaneous Injury.

Authors:  Lyn M Wise; Gabriella S Stuart; Nicola C Real; Stephen B Fleming; Andrew A Mercer
Journal:  Adv Wound Care (New Rochelle)       Date:  2018-08-01       Impact factor: 4.730

Review 4.  Emerging lymphatic imaging technologies for mouse and man.

Authors:  Eva M Sevick-Muraca; Sunkuk Kwon; John C Rasmussen
Journal:  J Clin Invest       Date:  2014-03-03       Impact factor: 14.808

5.  Discovering up-regulated VEGF-C expression in swine umbilical vein endothelial cells by classical swine fever virus Shimen.

Authors:  Pengbo Ning; Yanming Zhang; Kangkang Guo; Ru Chen; Wulong Liang; Zhi Lin; Helin Li
Journal:  Vet Res       Date:  2014-04-23       Impact factor: 3.683

6.  Nucleoside-modified VEGFC mRNA induces organ-specific lymphatic growth and reverses experimental lymphedema.

Authors:  Dániel Szőke; Gábor Kovács; Éva Kemecsei; László Bálint; Kitti Szoták-Ajtay; Petra Aradi; Andrea Styevkóné Dinnyés; Barbara L Mui; Ying K Tam; Thomas D Madden; Katalin Karikó; Raghu P Kataru; Michael J Hope; Drew Weissman; Babak J Mehrara; Norbert Pardi; Zoltán Jakus
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 14.919

Review 7.  In Vitro, In Vivo, and In Silico Models of Lymphangiogenesis in Solid Malignancies.

Authors:  Sophie Bekisz; Louis Baudin; Florence Buntinx; Agnès Noël; Liesbet Geris
Journal:  Cancers (Basel)       Date:  2022-03-16       Impact factor: 6.639

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.